19th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 March 2012, Seattle
1 June 2012. Related: Conference reports.
CROI 19 (Retrovirus) 2012
HIV and the brain: longitudinal results from CHARTER and other studies
1 June 2012. Related: Conference reports, Coinfections and complications.
Systolic blood pressure and risk of myocardial infarction in HIV infection
1 June 2012. Related: Conference reports, Coinfections and complications.
Risk of non-AIDS defining malignancies and immune suppression
1 June 2012. Related: Conference reports, Coinfections and complications.
Renal impairment in the D:A:D study
1 June 2012. Related: Conference reports, Antiretrovirals, Coinfections and complications.
Early data for rilpivirine long acting formulation supports further investigation for PrEP
1 June 2012. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Hormonal contraception: HIV transmission and progression rates
1 June 2012. Related: Conference reports, Women's health.
Darunavir use during pregnancy
1 June 2012. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy, PK and drug interactions.
19th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 March 2012
1 April 2012. Related: Conference reports.
Cure research takes centre stage: proof of concept for activating the latent reservoir
1 April 2012. Related: Conference reports, Cure-related research, Basic science and immunology.
Quad fixed-dose integrase combination: phase 3 studies at week 48
1 April 2012. Related: Conference reports, Antiretrovirals.
Dolutegravir studies continue to show promise
1 April 2012. Related: Conference reports, Antiretrovirals, Pregnancy.
Tenofovir prodrug: 10 day monotherapy study sets dose at 25 mg for easier coformulation
1 April 2012. Related: Conference reports, Antiretrovirals.
Paediatric formulations of ARVs: including an exciting new class
1 April 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Lower malaria risk in children receiving lopinavir/ritonavir-based compared to NNRTI-based ART
1 April 2012. Related: Conference reports, Paediatric care.
High prevalence of d4T-associated lipodystrophy including lipoatrophy in children
1 April 2012. Related: Conference reports, Antiretrovirals, Paediatric care.
Lopinavir/ritonavir monotherapy in children
1 April 2012. Related: Conference reports, Paediatric care.
Stopping treatment after early ART in infants
1 April 2012. Related: Conference reports, Paediatric care.
PrEP: PK modeling of daily TDF/FTC (Truvada) provides close to 100% protection against HIV infection
1 April 2012. Related: Conference reports, HIV prevention and transmission.
Risk of HIV reinfection may be similar to risk of initial HIV infection
1 April 2012. Related: Conference reports, HIV prevention and transmission.
Case report: homozygous CCR5 delta-32 protection overcome by infection with X4 virus
1 April 2012. Related: Conference reports, HIV prevention and transmission.
No association between atazanavir and MI or stroke in D:A:D study
1 April 2012. Related: Conference reports, Side effects, Coinfections and complications.
Hepatitis C coinfection studies
1 April 2012. Related: Conference reports, Hepatitis coinfection.
Herpes Zoster vaccine safe and effective in HIV positive people
1 April 2012. Related: Conference reports, Vaccines and microbicides.